Broad market→Weak timing→No reply
Problem 01
Scientific fit is easy to misread
A promising organization may still be wrong for the modality, development phase, patient population, workflow, or regulatory path.
← All industries
Outbound for Healthcare & medical
Reach healthcare buyers when the clinical or operating need is real.
Create carefully targeted conversations around clinical, operational, research, and implementation needs. Healthcare outreach has to respect specialized buyer criteria, evidence requirements, long evaluation cycles, and the operational or clinical stage that makes the offer relevant.
The Seqnced advantage
Coverage built around the market, not a recycled list.
For healthcare & medical, we connect account fit, a reason to engage now, and the right stakeholder before outreach begins.
01
Market
Biotech and CROs
02
Timing
A clinical milestone, trial phase, or regulatory event
03
Handoff
A relevant conversation with commercial context.
Account intelligenceTiming signalsMarket positioningMulti-touch outreachQualified handoff
Short answer
Who provides enterprise outbound for medtech and healthcare companies with long sales cycles?
Seqnced runs enterprise outbound for medtech, biotech, healthcare, CRO, and clinical-service providers selling into long sales cycles. Campaigns are matched to each account's clinical and commercial stage, and each stakeholder gets evidence that fits their decision: clinical, operational, regulatory, procurement, and executive. Seqnced operates the research, campaigns, and qualification, and your team takes the qualified conversations.
Accounts in this market
A representative account universe our systems are built to map and reach.
These companies illustrate the kinds of accounts active in healthcare & medical. The real list is built around your offer, territory, buyer, and timing signals.
M
Medable
K
Komodo Health
H
H1
I
Innovaccer
A
Aledade
C
Cityblock Health
R
Ro
M
Maven Clinic
I
Included Health
S
Spring Health
O
Omada Health
H
Headspace
T
Tempus
F
Flatiron Health
R
Recursion
B
Benchling
S
SOPHiA Genetics
S
Science 37
T
Tebra
R
Rightway
Illustrative market universe only. Inclusion does not imply a client relationship, engagement, or endorsement.
Where growth gets stuck
Why generic outbound breaks in healthcare & medical.
The market does not need more messages. It needs a campaign built around the conditions that make a conversation useful.
Wrong role→Long cycle→Stalled
Problem 02
The buyer group is highly specialized
Clinical, R&D, regulatory, procurement, operations, and executive stakeholders evaluate different forms of risk and value.
Generic angle→Low trust→Ignored
Problem 03
Timing follows milestones
Trials, approvals, funding, site activation, commercialization, and care-delivery change determine relevance.
What changes
An outbound system designed for how this market buys.
We connect the market thesis, account intelligence, messaging, infrastructure, campaign operation, and reply handoff so the strategy survives execution.
01
Stage-specific market mapping
Build the account universe around clinical, regulatory, operating, and commercialization criteria.
02
Milestone-based prioritization
Focus on companies approaching the stage where the service or technology becomes relevant.
03
Evidence-aware messaging
Connect proof, expertise, and the correct use case without relying on broad healthcare claims.
04
Careful qualification
Confirm scientific or operational fit before specialized team members spend time on discovery.
Division of responsibility
We operate the system. Your team advances the opportunity.
Seqnced works as the embedded outbound team behind the campaign, not as a list seller or a software login your team has to manage.
Seqnced runs
- Market and account research
- Data and sending infrastructure
- Positioning, copy, and testing
- Campaign management and follow-up
- Reply triage, qualification, and routing
Your team owns
- Subject-matter and commercial context
- Fast approvals on market and positioning
- Qualified sales conversations
- Discovery, proposals, and closing
- Feedback that sharpens the next sequence
Ready to map the market?
See what this system would look like for healthcare & medical.
The industry playbook
How we turn this market into a working sequence.
Diagnose the market
We define the clinical or operating use case, development stage, organization type, evidence requirements, buyer roles, and disqualifying conditions.
Map the buying committee
We turn healthcare and medical into named accounts, decision-makers, exclusions, and priority tiers instead of relying on a broad database pull.
Build and test the sequence
We create the outreach angle, data workflow, sending infrastructure, copy, follow-up, and approval loop, then test the assumptions against live market response.
Qualify and route interest
We confirm stage, application, stakeholder, timing, evidence expectations, and whether the next discussion should be scientific, operational, or commercial.
Signals that create timing
When the conversation becomes relevant
- A clinical milestone, trial phase, or regulatory event
- Funding, licensing, or commercialization activity
- New clinical, R&D, or operations leadership
- Expansion of sites, programs, services, or patient capacity
Best-fit conditions
When this motion is likely to work
- The scientific or operational use case is precise
- The addressable market can be researched responsibly
- The team can support evidence-led discovery
- Contract value supports a longer evaluation cycle
Relevant proof
Client work in and around healthcare & medical.
Every story shows the situation, what Seqnced operated, and the commercial outcome reported by the client.
$5M clinical-trial pipelineA campaign focused on biotech teams progressing Phase II clinical trials and testing.$5Mnew pipeline$750Kclosed businessRead the case study 
$135K opportunity pipelineTargeted outreach for a custom AI integrator serving regulated and technical markets.$135Kqualified pipeline37leads generatedRead the case study 
$20M Series A raise supportedA capital-introduction campaign spanning family offices, international VCs, and strategic industry partners.$20MSeries A raise supportedGlobalcapital market activatedRead the case study Industry FAQ
Questions teams ask before building the motion.
The market structure, decision-makers, proof requirements, timing signals, and acceptable level of personalization are different. We build those conditions into the campaign before outreach begins.
We handle market research, account and contact data, infrastructure, messaging, sequencing, campaign management, reply triage, qualification, and reporting. Your team approves the strategy, provides subject-matter context, takes qualified meetings, and advances opportunities.
Timing depends on the market, available proof, data complexity, and infrastructure readiness. We confirm the launch plan after the initial market and offer diagnosis rather than promising a universal timeline.
We measure qualified conversations, meetings that match the agreed criteria, opportunities created, and progression through your commercial process. Message volume alone is not treated as a business outcome.